Analytical variability among methods for the measurement of 25-hydroxyvitamin D: Still adding to the noise

American Journal of Clinical Pathology

Volumn 140, Issue 4, 2013, Pages 550-560

  Holmes, Earle W ^a   Garbincius, Jean ^b   McKenna, Kathleen M ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

25 Hydroxyvitamin D; Diagnosis; Direct immunoassay; Laboratory analysis; LC MS; Management; Method comparison; RIA; Vitamin D; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D;

ADOLESCENT; ADULT; AGED; ANALYTICAL ERROR; ARTICLE; BLOOD ANALYSIS EQUIPMENT; CHILD; CLINICAL EXAMINATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SCHOOL CHILD; SYSTEMATIC ERROR; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

25-HYDROXYVITAMIN D; DIAGNOSIS; DIRECT IMMUNOASSAY; LABORATORY ANALYSIS; LC/MS; MANAGEMENT; METHOD COMPARISON; RIA; VITAMIN D; VITAMIN D DEFICIENCY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMISTRY, CLINICAL; CHILD; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; IMMUNOASSAY; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; VITAMIN D; YOUNG ADULT;

EID: 84884912460     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPU2SKW1TFKSWY     Document Type: Article

References (45)

1. Holick MF, Siris ES, Binkley N, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005;90:3215-3224. (Pubitemid 41014278)
2. Lee JM, Smith JR, Philipp BL, et al. Vitamin D deficiency in a healthy group of mothers and newborn infants. Clin Pediatr (Phila). 2007;46:42-44. (Pubitemid 44924665)
3. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009;94:26-34.
4. Haddad JG, Chyu KJ. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab. 1971;33:992-995.
5. Hollis BW, Napoli JL. Improved radioimmunoassay for vitamin D and its use in assessing vitamin D status. Clin Chem. 1985;31:1815-1819. (Pubitemid 16012541)
6. Hollis BW. Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diabetes Obes. 2008;15:489-494.
7. Roth HJ, Zahn I, Alkier R, et al. Validation of the first automated chemiluminescence protein-binding assay for the detection of 25-hydroxycalciferol. Clin Lab. 2001;47:357-365. (Pubitemid 32685480)
8. Ersfeld DL, Rao DS, Body JJ, et al. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem. 2004;37:867-874. (Pubitemid 39209026)
9. Eisman JA, Shepard RM, DeLuca HF. Determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma using high-pressure liquid chromatography. Anal Biochem. 1977;80:298-305. (Pubitemid 8123739)
10. De Leenheer AP, Cruyl AA. Vitamin D3 in plasma: quantitation by mass fragmentography. Anal Biochem. 1978;91:293-303. (Pubitemid 9066825)
11. Vogeser M. Quantification of circulating 25-hydroxyvitamin D by liquid chromatography-tandem mass spectrometry. J Steroid Biochem Mol Biol. 2010;121:565-573.
12. Tai SS, Bedner M, Phinney KW. Development of a candidate reference measurement procedure for the determination of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in human serum using isotope-dilution liquid chromatography/tandem mass spectrometry. Anal Chem. 2010;82:1942-1948.
13. Stepman HC, Vanderroost A, Van Uytfanghe K, et al. Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem. 2011;57:441-448.
14. Sempos CT, Vesper HW, Phinney KW, et al. Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl. 2012;243:32-40.
15. Hollis BW. Editorial: the determination of circulating 25-hydroxyvitamin D: no easy task. J Clin Endocrinol Metab. 2004;89:3149-3151. (Pubitemid 38951876)
16. Wootton AM. Improving the measurement of 25-hydroxyvitamin D. Clin Biochem Rev. 2005;26:33-36.
17. Carter GD. 25-Hydroxyvitamin D: a difficult analyte. Clin Chem. 2012;58:486-488.
18. Herrmann M. The measurement of 25-hydroxy vitamin D- an analytical challenge. Clin Chem Lab Med. 2012;50:1873-1875.
19. Holmes EW, Garbincius J, McKenna KM. Non-linear analytical recovery in the DiaSorin Liaison immunoassay for 25-hydroxy vitamin D. Clin Chim Acta. 2011;412:2355-2356.
20. Cavalier E, Carlisi A, Bekaert AC, et al. Human anti-animal interference in DiaSorin Liaison total 25(OH)-vitamin D assay: towards the end of a strange story? Clin Chim Acta. 2012;413:527-527.
21. Holmes EW, Garbincius J, McKenna KM. Analytical performance characteristics of two new automated immunoassays for 25 hydroxy vitamin D. Endocrine Rev. 2012;33:MON-372.
22. Holmes EW, Garbincius J, McKenna KM. Excessive variability in a popular direct immunoassay for total 25 hydroxy vitamin D (t25OHD). FASEB J. 2012;26:643.6. http://www.fasebj.org/cgi/content/meeting-abstract/23/1- MeetingAbstracts/LB298. Accessed August 21, 2013.
23. Liaison® 25 OH Vitamin D Total Assay [directional insert us310600; 34825 8/10]. Stillwater, MN: DiaSorin; 2010.
24. Siemens Advia Centaur® XP Vitamin D Total (Vit D) Assay [directional insert 10698197-EN Rev.B]. Tarrytown, NY: Siemens Healthcare Diagnostics; 2011.
25. Siemens Advia Centaur® XP: recalibration of the vitamin D total assay beginning with reagent lot 134020. Customer Bulletin 10813470 Rev.A. Tarrytown, NY: Siemens Healthcare Diagnostics; 2012.
26. Architect®25-OH Vitamin D Assay [directional insert 3L52, G2-3231/R03]. Abbott Park, IL: Abbott Laboratories; 2011.
27. Clarke NJ. Vitamin D Testing and the LC/MS/MS Advantage. Madison, NJ: Quest Diagnostics; 2010. http://www.education.questdiagnostics.com/ presentations/vitamin-d-deficiencytesting-and-the-lc-ms-ms-advantage? presentation-id=99. Accessed February 26, 2013.
28. Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab. 2004;89:3152-3157. (Pubitemid 38951877)
29. Singh RJ, Taylor RL, Reddy GS, et al. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab. 2006;91:3055-3061. (Pubitemid 44271755)
30. Farrell CJ, Martin S, McWhinney B, et al. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem. 2012;58:531-542.
31. Janssen MJ, Wielders JP, Bekker CC, et al. Multicenter comparison study of current methods to measure 25-hydroxyvitamin D in serum. Steroids. 2012;77:1366-1372.
32. DiaSorin® 25-Hydroxyvitamin D 125I RIA Kit [directional insert: REF: 68100E]. Stillwater, MN: DiaSorin; 2010.
33. Stockl D, Sluss PM, Thienpont LM. Specifications for trueness and precision of a reference measurement system for serum/plasma 25-hydroxyvitamin D analysis. Clin Chim Acta. 2009;408:8-13.
34. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911-1930.
35. Looker AC, Johnson CL, Lacher DA, et al. Vitamin D status: United States, 2001-2006. NCHS Data Brief. 2011;(59):1-8.
36. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174. (Pubitemid 8054849)
37. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem. 1999;45:942-956. (Pubitemid 29340529)
38. Vitamin D External Quality Assessment Scheme (DEQAS) 25(OH)D Reports. London, UK: Charing Cross Hospital; April 2008 through January 2012 distributions. http://deqas. kpmd.co.uk/. Accessed August 21, 2013.
39. Farrell C, Soldo J, Williams P, et al. 25-Hydroxyvitamin D testing: challenging the performance of current automated immunoassays. Clin Chem Lab Med. 2012;50:1953-1963.
40. Hollis BW. Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am J Clin Nutr. 2008;88:507S-510S.
41. Carter GD. Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr Drug Targets. 2011;12:19-28.
42. Wallace AM, Gibson S, de la Hunty A, et al. Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations. Steroids. 2010;75:477-488.
43. Leventis P, Garrison L, Sibley M, et al. Underestimation of serum 25-hydroxyvitamin D by the Nichols Advantage Assay in patients receiving vitamin D replacement therapy. Clin Chem. 2005;51:1072-1074. (Pubitemid 40740905)
44. Yetley EA, Pfeiffer CM, Schleicher RL, et al. NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. J Nutr. 2010;140:2030S-2045S.
45. Carter GD. 25-Hydroxyvitamin D assays: the quest for accuracy. Clin Chem. 2009;55:1300-1302.